作者：
Preiss,D. [1]
;
Tikkanen,M.J. [2]
;
Welsh,P. [3]
;
Ford,I. [4]
;
Lovato,L.C. [5]
;
Elam,M.B. [6]
;
LaRosa,J.C. [7]
;
DeMicco,D.A. [8]
;
Colhoun,H.M. [9]
;
Goldenberg,I. [10]
;
Murphy,M.J. [11]
;
MacDonald,T.M. [12]
;
Pedersen,T.R. [13]
;
Keech,A.C. [14]
;
Ridker,P.M. [15]
;
Kjekshus,J. ;
Sattar,N. ;
McMurray,J.J.V.
作者单位：
Medicines Monitoring Unit, Division of Medical Sciences, University of Dundee, Dundee, United
[1]
Memphis Veterans Affairs Medical Center, Memphis, TN, United States
[2]
Department of Biochemical Medicine, University of Dundee, Dundee, United Kingdom
[3]
University of Helsinki and Division of Cardiology, Helsinki University Hospital, Folkhalsan
[4]
University of Oslo and Centre for Preventative Medicine, Oslo University Hospital, Ulleval, Oslo
[5]
BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12
[6]
Cardiac Rehabilitation Institute and Israeli Society for the Prevention of Heart Attacks, Leviev
[7]
Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom
[8]
Pfizer Global Pharmaceuticals, New York, NY, United States
[9]
Division of Public Health Sciences, Department of Biostatistical Science, Wake Forest University
[10]
NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
[11]
Medical Research Institute, University of Dundee, Dundee, United Kingdom
[12]
Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
[13]
SUNY Health Science Center at Brooklyn, New York, NY, United States
[14]
Harvard Medical School, Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, United
[15]
发布时间
2013-11-20
换一批
换一批
